Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
弗雷明汉研究中的精确监测和评估:AD 的认知、MRI、遗传和生物标志物前体
基本信息
- 批准号:10468279
- 负责人:
- 金额:$ 545.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease riskArchivesBiological MarkersBlood VesselsBostonBrainChronicClinicalCognitiveCohort StudiesCommunitiesComplementConsensusDataData SetDementiaDetectionDiagnosisDiseaseEarly DiagnosisElderlyFamilyFinancial costFramingham Heart StudyFutureGenerationsGenesGeneticGenetic MarkersGenetic Predisposition to DiseaseGoalsImageImpaired cognitionInflammationInflammatoryInfrastructureLeadLeadershipLife StyleLinkMRI ScansMagnetic Resonance ImagingMeasuresMonitorNeurogliaNeurologicNeuropsychological TestsNeuropsychologyPaperParentsParticipantPathogenesisPathway interactionsPeripheralPersonsPhenotypePilot ProjectsPlayProteinsPublishingResearchResearch PersonnelResourcesRiskRisk FactorsRoleSpousesStructureSymptomsTimeUniversitiesaging brainbasebrain healthbrain magnetic resonance imagingcare costscentral databasecognitive changecohortcomorbiditydata resourcedata sharingdementia riskdigitaldisorder preventionearly detection biomarkersgenetic analysisgenetic associationgenome-widehealth dataimprovedinnovationlifestyle datalongitudinal analysismembermiddle agemulti-ethnicneuropathologynew therapeutic targetnoveloffspringorganizational structurepre-clinicalprogramsresearch studyresilienceresponsesocietal coststargeted treatmenttrait
项目摘要
Since 1976, the Framingham Heart Study (FHS) has surveilled participants for incident dementia, initially, in the
Generation 1 participants, starting 1979 in the Generation 2 cohorts and in 1994 with the smaller multi-ethnic
Omni Generation 1 cohort. As the oldest of the Generation 3 and Omni Generation 2 move into the age of
dementia risk, we extended surveillance to these two younger cohorts. Baseline and repeat neuropsychological
(NP) assessments and brain magnetic resonance imaging (MRI) scans have been conducted since 1999 on the
Gen 1, Gen 2 and OmniGen 2 cohorts and since 2008 with the younger cohorts. Importantly, over nearly 7
decades, FHS has collected many co- morbid features linked to future risk of late life cognitive decline and
dementia across these cohorts when they were early to middle age. Complementing the health and lifestyle data
is the availability of genetic and peripheral biomarker data. Further, beginning in 2005, digital capture of spoken
responses was added to NP testing. This was extended to written responses in 2011, allowing quantification of
spoken and written responses at levels of granularity that can detect preclinical cognitive changes that traditional
NP test scores cannot measure. Previously, we have capitalized on the multi-generation uniqueness using
genome-wide approaches to discern novel genetic associations for AD risk and AD-related traits that were not
identified in datasets up to 20 times larger. The primary goal of this FHS Brain Aging Program (FHS-BAP) is
to continue dementia surveillance, extend longitudinal characterization of cognitive phenotypes and brain
structure, bring added resources to the brain donation program including neuropathological examination, in the
FHS cohorts in order to identify new and expand on known AD-related genetic and other risk factors and
biomarkers and to pursue innovative research about the vascular and inflammatory basis of AD. Another central
objective of FHS-BAP is to facilitate more widespread sharing of this extraordinary AD data resource with the
broader scientific community. Under a new organizational structure, Administrative, Clinical, Neuropathology and
Data cores will provide a formal management and infrastructure to continue incident dementia surveillance, NP
and MRI assessments of surviving participants of all FHS cohorts, and perform neuropathological examination
of brains obtained through the FHS brain donation program. The FHS-BAP will feature three inter-related projects
that have a focus on vascular and inflammatory contributors to AD. One project will identify factors that are
associated with AD risk and resilience using longitudinal analyses of FHS data including genetic, various `omic
genetic, clinical, imaging, lifestyle and other traits. A second project will investigate the link between AD genetic
vulnerabilities and chronic peripheral inflammation. A third project will determine genetic and protein alterations
of complement-related genes and glial cell phenotypes that modulate cognitive trajectories and
neuropathological profiles. Finally, this program will promote using FHS-BAP data, especially by early-stage and
non-AD investigators through a pilot projects program and through enhanced and proactive data sharing efforts.
自1976年以来,心脏脆弱性研究(FHS)一直在监测参与者的痴呆事件,最初,
第一代参与者,从1979年开始在第二代队列中,1994年与较小的多种族
Omni第1代队列。随着第三代和第二代中最老的一代进入了
痴呆风险,我们将监测扩展到这两个年轻的队列。基线和重复神经心理学检查
(NP)自1999年以来,已经进行了评估和脑磁共振成像(MRI)扫描,
Gen 1、Gen 2和OmniGen 2队列以及自2008年以来的年轻队列。重要的是,超过7
几十年来,FHS已经收集了许多与晚年认知能力下降的未来风险相关的共病特征,
在这些人群中,当他们处于早期到中年时,他们患有痴呆症。补充健康和生活方式数据
是遗传和外周生物标志物数据的可用性。此外,从2005年开始,
将响应添加到NP测试中。2011年,这一做法扩大到书面答复,以便对
在粒度水平上的口头和书面反应,可以检测到传统的临床前认知变化,
NP测试分数无法衡量。以前,我们利用了多代的独特性,
全基因组方法来识别AD风险和AD相关特征的新遗传关联,
在大20倍的数据集中识别。这个FHS脑老化计划(FHS-BAP)的主要目标是
继续痴呆症监测,扩展认知表型和大脑的纵向表征
结构,为大脑捐赠计划带来额外的资源,包括神经病理学检查,
FHS队列,以确定新的和扩展已知的AD相关遗传和其他风险因素,
生物标志物,并追求创新的研究,血管和炎症基础的AD。另一个核心
FHS-BAP的目标是促进更广泛地共享这一非凡的AD数据资源,
更广泛的科学界。在新的组织结构下,行政、临床、神经病理学和
数据核心将提供正式的管理和基础设施,以继续进行痴呆症事件监测,NP
所有FHS队列的存活参与者的MRI评估,并进行神经病理学检查
通过FHS大脑捐赠计划获得的大脑。FHS-BAP将包括三个相互关联的项目
主要研究AD的血管和炎症因素。其中一个项目将确定
与AD风险和弹性相关,使用FHS数据的纵向分析,包括遗传、各种“组学”
遗传、临床、成像、生活方式和其他特征。第二个项目将调查AD遗传学之间的联系,
脆弱性和慢性外周炎症。第三个项目将确定基因和蛋白质的改变
调节认知轨迹的补体相关基因和神经胶质细胞表型,
神经病理学特征最后,本计划将促进使用FHS-BAP数据,特别是通过早期和
非AD调查人员通过试点项目计划,并通过加强和积极的数据共享工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rhoda Au其他文献
Rhoda Au的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rhoda Au', 18)}}的其他基金
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study
弗雷明汉研究中用于阿尔茨海默病风险检测的精确大脑健康监测
- 批准号:
10625625 - 财政年份:2021
- 资助金额:
$ 545.17万 - 项目类别:
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study: Black & AA Recruitment Supplement
弗雷明汉研究中用于阿尔茨海默病风险检测的精确大脑健康监测:黑人
- 批准号:
10786286 - 财政年份:2021
- 资助金额:
$ 545.17万 - 项目类别:
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study
弗雷明汉研究中用于阿尔茨海默病风险检测的精确大脑健康监测
- 批准号:
10214162 - 财政年份:2021
- 资助金额:
$ 545.17万 - 项目类别:
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
弗雷明汉研究中的精确监测和评估:AD 的认知、MRI、遗传和生物标志物前体
- 批准号:
10670318 - 财政年份:2020
- 资助金额:
$ 545.17万 - 项目类别:
Cognitive Heterogeneity in those with high Alzheimer's Disease Risk
阿尔茨海默病高风险人群的认知异质性
- 批准号:
9975371 - 财政年份:2020
- 资助金额:
$ 545.17万 - 项目类别:
Cognitive Heterogeneity in those with high Alzheimer's Disease Risk
阿尔茨海默病高风险人群的认知异质性
- 批准号:
10404703 - 财政年份:2020
- 资助金额:
$ 545.17万 - 项目类别:
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
弗雷明汉研究中的精确监测和评估:AD 的认知、MRI、遗传和生物标志物前体
- 批准号:
10256768 - 财政年份:2020
- 资助金额:
$ 545.17万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 545.17万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 545.17万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 545.17万 - 项目类别:
Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 545.17万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 545.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 545.17万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 545.17万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 545.17万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 545.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 545.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)